Skip to main content
Log in

Optimal screening to prevent CHF in childhood cancer survivors?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Wong FL, et al. Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure. Annals of Internal Medicine 160: 672-83, No. 10, 20 May 2014. Available from: URL: http://doi.org/10.7326/M13-2498

  2. Yeh JM, et al. Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects. Annals of Internal Medicine 160: 661-71, No. 10, 20 May 2014. Available from: URL: http://doi.org/10.7326/M13-2266

  3. Cost-Effectiveness of Screening for Asymptomatic Left Ventricular Dysfunction in Childhood Cancer Survivors. Internet Document : 28 May 2014. Available from: URL: 10.7326/M14-0823

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Optimal screening to prevent CHF in childhood cancer survivors?. PharmacoEcon Outcomes News 704, 6 (2014). https://doi.org/10.1007/s40274-014-1288-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1288-y

Navigation